PDC*line Pharma SAS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC (NCT03970746) | PDC*line Pharma SAS | 2019-09-10 |
Track PDC*line Pharma SAS automatically
Every clearance here is in the API, with alerts when new ones post.